Down -54.05% in 4 Weeks, Here's Why Phathom Pharmaceuticals (PHAT) Looks Ripe for a TurnaroundZacks Investment Research • Friday
Phathom Pharmaceuticals (PHAT) Upgraded to Buy: Here's What You Should KnowZacks Investment Research • 11/19/24
Phathom Pharmaceuticals, Inc. (PHAT) Reports Q3 Loss, Tops Revenue EstimatesZacks Investment Research • 11/07/24
Phathom Pharmaceuticals to Report Third Quarter 2024 Financial Results and Provide Business Update on Thursday, November 7, 2024GlobeNewsWire • 10/28/24
Phathom Pharmaceuticals to Present VOQUEZNA® Data at the American College of Gastroenterology (ACG) 2024 Annual MeetingGlobeNewsWire • 10/27/24
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT)PRNewsWire • 09/25/24
Phathom Pharmaceuticals Announces Pricing of $130 Million Offering of Common Stock and Pre-Funded WarrantsGlobeNewsWire • 08/19/24
Phathom Pharmaceuticals, Inc. (PHAT) Reports Q2 Loss, Tops Revenue EstimatesZacks Investment Research • 08/08/24
Phathom Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business UpdateGlobeNewsWire • 08/08/24
Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA® (vonoprazan) Tablets for the Relief of Heartburn Associated with Non-Erosive GERD in AdultsGlobeNewsWire • 07/18/24
Phathom Pharmaceuticals: Time To Deliver Promise Of Voquezna After Frustrating DelaysSeeking Alpha • 06/26/24
Phathom Pharmaceuticals, Inc. (PHAT) Reports Q1 Loss, Lags Revenue EstimatesZacks Investment Research • 05/09/24
Phathom Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business UpdateGlobeNewsWire • 05/09/24
Phathom Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceGlobeNewsWire • 04/03/24
Phathom Pharmaceuticals Launches Direct-to-Consumer Campaign, “VOQUEZNA Can Kick Some Acid”GlobeNewsWire • 03/26/24
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateGlobeNewsWire • 03/07/24
Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 7, 2024GlobeNewsWire • 02/29/24